ETC
TYRA icon

Exchange Traded Concepts’s Tyra Biosciences TYRA Stock Holding History

Exchange Traded Concepts’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,861
Closed -$110K – 1507
2025
Q1 		$110K Buy
11,861
+3,550
+43% +$45.9K ﹤0.01% 1125
2024
Q4 		$116K Hold
8,311
– – ﹤0.01% 1124
2024
Q3 		$195K Sell
8,311
-3,934
-32% -$82.6K ﹤0.01% 981
2024
Q2 		$196K Sell
12,245
-3,808
-24% -$65.5K ﹤0.01% 879
2024
Q1 		$263K Buy
16,053
+6,522
+68% +$107K 0.01% 849
2023
Q4 		$132K Buy
9,531
+2,417
+34% +$31.3K ﹤0.01% 848
2023
Q3 		$98K Sell
7,114
-1,753
-20% -$26K ﹤0.01% 903
2023
Q2 		$151K Buy
+8,867
New +$129K ﹤0.01% 839

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Exchange Traded Concepts's TYRA Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Tyra Biosciences (TYRA) in Q2 2025, closing a stake of 11,861 shares — an estimated $110K sold.

Exchange Traded Concepts first reported a position in TYRA in Q2 2023 and held it in 8 quarters. The position peaked at $263K in Q1 2024. 121 funds tracked by Wall St. Rank hold TYRA as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Tyra Biosciences position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 11,861 Tyra Biosciences shares in Q2 2025, an estimated $110K.
  • Exchange Traded Concepts first reported a position in Tyra Biosciences in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Tyra Biosciences position peaked at $263K in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.